Biomarin Pharmaceutical shares owned by Shenkman Capital Management
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Shenkman Capital Management
from 13F filings
Historical chart of Shenkman Capital Management investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Shenkman Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $10B | 11M | 971.33 |
| 2024-03-31 | $11B | 11M | 1011.07 |
| 2023-12-31 | $12B | 12M | 1041.12 |
| 2023-09-30 | $237M | 237k | 1000.32 |
| 2023-06-30 | $240M | 237k | 1011.90 |
| 2023-03-31 | $250M | 237k | 1052.73 |
| 2022-12-31 | $256M | 237k | 1081.16 |
| 2022-09-30 | $238k | 237k | 1.00 |
| 2022-06-30 | $237k | 237k | 1.00 |
| 2021-12-31 | $3.0M | 2.9M | 1.05 |
| 2021-09-30 | $18M | 18M | 1.01 |
| 2021-06-30 | $15M | 15M | 1.01 |
More positions owned by Shenkman Capital Management
View all positions for Shenkman Capital Management